The Campbell Foundation   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Annapolis MD United States (1998)

Organization Overview

First Clinical Trial
2001
NCT00025753
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

The Campbell Foundation